mk, my logic is this....... I know all of the history here since the REDUCE-IT results were published but if I were just now hearing about this company I would see:
- A drug that is derived from fish ( I like that )
- A drug that has years of a proven safety profile
- A drug that reduces Triglycerides and is proven to do so
- A drug that reduces CV risk an additional 30% when combined with a statin. (nothing else does that)
- A drug with patent protection in the US for the CV indication for what, another 8 years?
- A drug that has EU marketing rights and protection until 2039 and is just now, albeit slowly penetrating those markets
- An infringement appeal against Hikma that may turn favorable to us any day now
- More and more publications coming from EU promoting the benefits of IPE
- China is approved for Trig lowering and could be approved for CV reduction (I'd rather have them in the fold than not)
- Ongoing studies and trials for other benefits to taking V
- A healthy cash position and no debt
- A possible share buyback of $50 million worth of shares
- A share price of .70 cents
- So many things have gone against us that something has to break for us
- And it just feels like some big pharma could buy this company with loose change from all the profits they make
So that is why I keep adding to my position, and if I'm reading the tea leaves correctly which is very debatable, I will be able to accelerate my retirement plans...... and if not, I'll be very disappointed in the risk I've taken. But it's a high upside risk at these prices.
What is your logic for selling?
